IDXX logo

IDXXIdexx Laboratories Inc

$560.88
$2.97
(0.53%)
Today
Closed $560.88
$0.00
(0.00%)
After Hours
Updated: 04:42 PM EDT
EarningsAug 3
Mkt Cap$44.01B
Vol516,570.00
News
all
press releases
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
More News
News Placeholder
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier...
Business Wire
News Placeholder
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into Catalyst CLIPs, making complete kidney function evaluation part of the most common point-of-care chemistry profiles. Available beginning in June to...
Business Wire
News Placeholder
The Biology Came First.
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at...
Business Wire
News Placeholder
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat...
Business Wire
News Placeholder
Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)?
Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX...
Yahoo! Finance: News
News Placeholder
Top Analyst Reports for Meta, Pfizer & Salesforce
Meta ramps up AI infrastructure and ad tools as Pfizer rebounds and Salesforce expands AI offerings amid macro pressures.
Zacks
News Placeholder
IDEXX Laboratories Q1 Earnings Call Highlights
IDEXX Laboratories (NASDAQ:IDXX) reported first-quarter 2026 results that management described as an exceptional start to the year, driven by continued execution in its companion animal business and...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.